Recent studies emphasise that the current approach does not fully capture the needs and experiences of patients with rare tumours

Adding first-line checkpoint inhibition to standard treatment shows promise to improve response in women

A recent EURACAN survey highlights a high uptake of recommendations from medical oncologists, potentially leading to improved patients’ survival